What is the recommended use for Tudorza Pressair after opening?

Tudorza Pressair, which contains aclidinium bromide for the maintenance treatment of chronic obstructive pulmonary disease (COPD), has specific guidelines regarding its use after opening to ensure its effectiveness and safety. The recommended use after opening is 45 days. This timeframe is essential because the medication can degrade or lose potency over time when exposed to air and humidity. Following the 45-day guideline helps ensure that patients receive the full therapeutic benefit of the medication without risking diminished efficacy, which could impact their respiratory health management. Thus, it is crucial for patients and healthcare providers to adhere to this timeframe after the device is opened.